Mirjam A Lips1, Jan Bert van Klinken2, Hanno Pijl1, Ignace Janssen3, Ko Willems van Dijk4, Frits Koning5, Vanessa van Harmelen6. 1. Department of Endocrinology and Metabolic Diseases, Leiden University Medical Center, Leiden, the Netherlands. 2. Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Leiden, the Netherlands; Department of Human Genetics, Leiden University Medical Center, Leiden, the Netherlands. 3. Department of Surgery, Rijnstate Hospital, Arnhem, the Netherlands. 4. Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Leiden, the Netherlands; Department of Human Genetics, Leiden University Medical Center, Leiden, the Netherlands; Department of Endocrinology and Metabolic Diseases, Leiden University Medical Center, Leiden, the Netherlands. 5. Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, Leiden, the Netherlands. 6. Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Leiden, the Netherlands; Department of Human Genetics, Leiden University Medical Center, Leiden, the Netherlands. Electronic address: V.J.A.van_Harmelen@lumc.nl.
Abstract
INTRODUCTION: Weight loss interventions such as Roux-en-Y gastric bypass (RYGB) and very low calorie diets (VLCD) lead to improvement of glucose metabolism in obese individuals with type-2 diabetes. Weight loss can also positively influence the unfavorable inflammatory profile associated with obesity. However, a direct comparison of the effect of VLCD and RYGB on systemic inflammation is lacking. METHODS: Systemic inflammation was investigated in age- and BMI-matched morbidly obese T2DM women by determining the number and activation- or memory status of peripheral blood leukocytes by flow cytometry, in addition to measuring circulating levels of cytokines and CRP. Systemic inflammation was assessed one month before and three months after RYGB (n=15) or VLCD (n=12). An age matched group of lean women (n=12) was studied as control group. RESULTS: Three months after the intervention, CRP and leptin levels were reduced whereas adiponectin levels were increased both by RYGB and VLCD. TNF-α levels were increased by RYGB, but reduced by VLCD. IL-2 and IL-6 levels were reduced and IL-4 levels were increased by VLCD but not affected by RYGB. The number of activated peripheral cytotoxic T (CD8+CD25+) and B (CD19+CD38+) cells was significantly higher after RYGB than after VLCD. CONCLUSION: In conclusion, RYGB and VLCD have differential effects on the activation status of peripheral leukocytes and levels of cytokines in obese women with T2DM, despite comparable weight loss three months after the intervention. VLCD seems to have more favorable effects on the inflammatory profile as compared to RYGB.
INTRODUCTION:Weight loss interventions such as Roux-en-Y gastric bypass (RYGB) and very low calorie diets (VLCD) lead to improvement of glucose metabolism in obese individuals with type-2 diabetes. Weight loss can also positively influence the unfavorable inflammatory profile associated with obesity. However, a direct comparison of the effect of VLCD and RYGB on systemic inflammation is lacking. METHODS: Systemic inflammation was investigated in age- and BMI-matched morbidly obese T2DM women by determining the number and activation- or memory status of peripheral blood leukocytes by flow cytometry, in addition to measuring circulating levels of cytokines and CRP. Systemic inflammation was assessed one month before and three months after RYGB (n=15) or VLCD (n=12). An age matched group of lean women (n=12) was studied as control group. RESULTS: Three months after the intervention, CRP and leptin levels were reduced whereas adiponectin levels were increased both by RYGB and VLCD. TNF-α levels were increased by RYGB, but reduced by VLCD. IL-2 and IL-6 levels were reduced and IL-4 levels were increased by VLCD but not affected by RYGB. The number of activated peripheral cytotoxic T (CD8+CD25+) and B (CD19+CD38+) cells was significantly higher after RYGB than after VLCD. CONCLUSION: In conclusion, RYGB and VLCD have differential effects on the activation status of peripheral leukocytes and levels of cytokines in obesewomen with T2DM, despite comparable weight loss three months after the intervention. VLCD seems to have more favorable effects on the inflammatory profile as compared to RYGB.
Authors: Alexandra R Himel; Erin B Taylor; Charles L Phillips; Bradley A Welch; Redin A Spann; Sibali Bandyopadhyay; Bernadette E Grayson Journal: Exp Biol Med (Maywood) Date: 2019-06-18
Authors: Stefan Jordan; Navpreet Tung; Maria Casanova-Acebes; Christie Chang; Claudia Cantoni; Dachuan Zhang; Theresa H Wirtz; Shruti Naik; Samuel A Rose; Chad N Brocker; Anastasiia Gainullina; Daniel Hornburg; Sam Horng; Barbara B Maier; Paolo Cravedi; Derek LeRoith; Frank J Gonzalez; Felix Meissner; Jordi Ochando; Adeeb Rahman; Jerry E Chipuk; Maxim N Artyomov; Paul S Frenette; Laura Piccio; Marie-Luise Berres; Emily J Gallagher; Miriam Merad Journal: Cell Date: 2019-08-22 Impact factor: 41.582
Authors: L H Wijngaarden; A E Taselaar; F Nuijten; E van der Harst; R A Klaassen; T M Kuijper; F Jongbloed; G Ambagtsheer; M Klepper; J N M IJzermans; R W F de Bruin; N H R Litjens Journal: Front Immunol Date: 2022-07-04 Impact factor: 8.786